Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA.
Science (Impact Factor: 33.61). 04/2009; 323(5922):1693-7. DOI: 10.1126/science.1167983
Source: PubMed


Protein folding in the endoplasmic reticulum is a complex process whose malfunction is implicated in disease and aging. By using the cell's endogenous sensor (the unfolded protein response), we identified several hundred yeast genes with roles in endoplasmic reticulum folding and systematically characterized their functional interdependencies by measuring unfolded protein response levels in double mutants. This strategy revealed multiple conserved factors critical for endoplasmic reticulum folding, including an intimate dependence on the later secretory pathway, a previously uncharacterized six-protein transmembrane complex, and a co-chaperone complex that delivers tail-anchored proteins to their membrane insertion machinery. The use of a quantitative reporter in a comprehensive screen followed by systematic analysis of genetic dependencies should be broadly applicable to functional dissection of complex cellular processes from yeast to human.

Download full-text


Available from: Maya Schuldiner, Dec 27, 2013
  • Source
    • "The most advanced drug candidate GNF179 provided protection against a challenge with P. berghei sporozoite, demonstrating in vivo activity against the early-liver stage of the disease. The putative target for GNF179 is pfcar1, an uncharacterized protein that is postulated to be involved in protein folding that is assumed to be essential for the biology of both the liver and blood stages of Plasmodium infection (Jonikas et al. 2009). More recently, a team at AstraZeneca utilized another high-throughput imaging assay to identify 2 more novel classes of fast-acting antiplasmodial agents; the N-aryl-2- aminobenzimidazoles, which targets the asexual blood stages of P. falciparum (Ramachandran et al. 2014), and the triaminopyrimidines (TAPs), which may potentially be used for single-dose treatment of malaria when used in multidrug combination therapy (Hameed et al. 2015). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The global emergence of multi-drug resistant bacteria invokes an urgent and imperative necessity for the identification of novel antimicrobials. The general lack of success in progressing novel chemical entities from target-based drug screens have prompted calls for radical and innovative approaches for drug discovery. Recent developments in chemical biology and target deconvolution strategies have revived interests in the utilization of whole-cell phenotypic screens and resulted in several success stories for the discovery and development novel drug candidates and target pathways. In this review, we present and discuss recent chemical biology approaches focusing on the discovery of novel targets and new lead molecules for the treatment of human bacterial and protozoan infections.
    Archives of Pharmacal Research 08/2015; 38(9). DOI:10.1007/s12272-015-0645-0 · 2.05 Impact Factor
  • Source
    • "More recently it became clear that the UPR is activated not only by accumulating misfolded proteins but also in response to diverse conditions of a perturbed lipid metabolism (Promlek et al., 2011; Volmer et al., 2013) (Figure 2). Systematic screens in S. cerevisiae highlighted an intense genetic crosstalk between the UPR and lipid metabolism (Schuldiner et al., 2005; Jonikas et al., 2009; Surma et al., 2013). A deregulated fatty acid metabolism induced by an interference with the OLE pathway, for example, potently activates the UPR (Surma et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Biological membranes are dynamic and complex assemblies of lipids and proteins. Eukaryotic lipidomes encompass hundreds of distinct lipid species and we only begin to understand their role and function. This review focuses on recent advances in the field of lipid sensors and discusses methodical approaches to identify and characterize putative sensor domains. We elaborate on the role of integral and conditionally membrane-associated sensor proteins, their molecular mechanisms, and identify open questions in the emerging field of membrane homeostasis.
    Biological Chemistry 04/2015; DOI:10.1515/hsz-2015-0130 · 3.27 Impact Factor
  • Source
    • "It is also possible that some cellular changes are caused by Erv41–Erv46 function as an anterograde cargo receptor for specific proteins as proposed for Golgi localization of Ktr4 (Noda et al., 2014). However, we note that the erv41 and erv46 strains do not display an activated unfolded protein response as reported for other anterograde cargo receptor deletion strains (Jonikas et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Signal-dependent sorting of proteins in the early secretory pathway is required for dynamic retention of endoplasmic reticulum (ER) and Golgi components. In this study, we identify the Erv41-Erv46 complex as a new retrograde receptor for retrieval of non-HDEL-bearing ER resident proteins. In cells lacking Erv41-Erv46 function, the ER enzyme glucosidase I (Gls1) was mislocalized and degraded in the vacuole. Biochemical experiments demonstrated that the luminal domain of Gls1 bound to the Erv41-Erv46 complex in a pH-dependent manner. Moreover, in vivo disturbance of the pH gradient across membranes by bafilomycin A1 treatment caused Gls1 mislocalization. Whole cell proteomic analyses of deletion strains using stable isotope labeling by amino acids in culture identified other ER resident proteins that depended on the Erv41-Erv46 complex for efficient localization. Our results support a model in which pH-dependent receptor binding of specific cargo by the Erv41-Erv46 complex in Golgi compartments identifies escaped ER resident proteins for retrieval to the ER in coat protein complex I-formed transport carriers. © 2015 Shibuya et al.
    The Journal of Cell Biology 01/2015; 208(2):197-209. DOI:10.1083/jcb.201408024 · 9.83 Impact Factor
Show more